VS Creator's full simulation capability enabled nearly a month of development and testing with historical images before the physical hardware arrived. The camera's calibration tools corrected dramatic ...

The Cavaliers and Raptors are set to face off in an intriguing No. 4 vs. No. 5 opening-round playoff series in the East. The Donovan Mitchell and James Harden backcourt will make their highly ...

The Toronto Raptors are set to reignite their postseason rivalry with the Cleveland Cavaliers. Here is everything you need to know about the first-round schedule, key matchups, and how to watch. The ...

Male-pattern hair loss affects 80% of men at some point in their lifetime (and female-pattern hair loss affects half of all women over the age of 70). But “until recently, we knew remarkably little ...

This is read by an automated voice. Please report any issues or inconsistencies here. The boy who lived is back. HBO on Wednesday revealed the release date and ...

The "Harry Potter" TV reboot is coming sooner than fans thought. On March 25, HBO announced the new adaptation of J.K. Rowling's wizarding world will debut on HBO Max in 2026 and gave a taste of the ...

The show's first photo shows Harry approaching the Quidditch pitch and teased a trailer coming Wednesday. By James Hibberd Writer-at-Large HBO revealed the first photo from its highly anticipated ...

In this video, we pushed the limits of the Sodastream to see how much carbonation it can produce. The results are quite revealing. Donald Trump issues peace talks ultimatum to Iran: 'We're ready to go ...

“Stranger Things” fans will soon be able to return to Hawkins through a whole new medium. Arrow Films and Netflix have teamed up to release “Stranger Things: The Complete Series” for Blu-Ray and 4K ...

Page Six may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. A new drama about love, resilience and transformation ...

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...